HAL
47
-6
MDLZ
22
-2
UHS
60
-2
PPL
60
-2
SE
43
3
NSC
59
-3
CF
42
-6
DG
72
2
ISRG
66
-2
INTU
63
7
HST
58
-4
BEN
50
-3
IFF
53
2
DVN
39
-4
FLR
40
-2
MCHP
45
-4
SIG
52
5
LMT
60
-2
TRV
48
-10
NWS
52
4
HAL
47
-6
MDLZ
22
-2
UHS
60
-2
PPL
60
-2
SE
43
3
NSC
59
-3
CF
42
-6
DG
72
2
ISRG
66
-2
INTU
63
7
HST
58
-4
BEN
50
-3
IFF
53
2
DVN
39
-4
FLR
40
-2
MCHP
45
-4
SIG
52
5
LMT
60
-2
TRV
48
-10
NWS
52
4
Financhill
Back

Direxion Daily S&P Biotech Bear 3X Shares Vs. Nektar Therapeutics Industry Stock Comparison

Sell
24

LABD
Direxion Daily S&P Biotech Bear 3X Shares

Last Price:
$22.04
Seasonality Move:
-0.37%
Sell
42

NKTR
Nektar Therapeutics

Last Price:
$44.64
Seasonality Move:
11.58%
Sell
24
Direxion Daily S&P Biotech Bear 3X Shares (LABD) is a Sell

Is Direxion Daily S&P Biotech Bear 3X Shares a Buy, Sell or Hold?

  • The current Direxion Daily S&P Biotech Bear 3X Shares [LABD] share price is $21.65. The Score for LABD is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
  • LABD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $49.16. The Score for NKTR is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • NKTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

LABD Stock Price Chart

What is Direxion Daily S&P Biotech Bear 3X Shares's stock price today?

  • The Direxion Daily S&P Biotech Bear 3X Shares share price today is $21.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LABD is experiencing slight selling pressure.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $49.16
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing slight buying pressure.

LABD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.11 Sell
Relative Strength Index (14 RSI): 37.3 Sell
Chaikin Money Flow: -459847 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.43 Sell
Relative Strength Index (14 RSI): 38.92 Sell
Chaikin Money Flow: 341847 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

LABD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 21.3 Buy
20-day SMA: 22.62 Sell
50-day SMA: 27.59 Sell
200-day SMA: 61.56 Sell
8-day EMA: 21.52 Buy
20-day EMA: 23 Sell
50-day EMA: 28.78 Sell
200-day EMA: 51.63 Sell

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 54.87 Sell
20-day SMA: 57.43 Sell
50-day SMA: 58.05 Sell
200-day SMA: 31.04 Buy
8-day EMA: 54.11 Sell
20-day EMA: 56.28 Sell
50-day EMA: 55.42 Sell
200-day EMA: 38.13 Buy

Direxion Daily S&P Biotech Bear 3X Shares Earnings Growth & LABD Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.

Direxion Daily S&P Biotech Bear 3X Shares Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):